West Pharmaceutical Services Inc
NYSE:WST
Wall Street
Price Targets
WST Price Targets Summary
West Pharmaceutical Services Inc
According to Wall Street analysts, the average 1-year price target for WST is 413.97 USD with a low forecast of 358.55 USD and a high forecast of 493.5 USD.
Operating Income
Forecast
Operating Income Estimate
West Pharmaceutical Services Inc
For the last 8 years the compound annual growth rate for West Pharmaceutical Services Inc's operating income is 24%. The projected CAGR for the next 3 years is 10%.
Net Income
Forecast
Net Income Estimate
West Pharmaceutical Services Inc
For the last 8 years the compound annual growth rate for West Pharmaceutical Services Inc's net income is 26%. The projected CAGR for the next 3 years is 8%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is WST's stock price target?
Price Target
413.97
USD
According to Wall Street analysts, the average 1-year price target for WST is 413.97 USD with a low forecast of 358.55 USD and a high forecast of 493.5 USD.
What is West Pharmaceutical Services Inc's Revenue forecast?
Projected CAGR
7%
For the last 8 years the compound annual growth rate for West Pharmaceutical Services Inc's revenue is 10%. The projected CAGR for the next 3 years is 7%.
What is West Pharmaceutical Services Inc's Operating Income forecast?
Projected CAGR
10%
For the last 8 years the compound annual growth rate for West Pharmaceutical Services Inc's operating income is 24%. The projected CAGR for the next 3 years is 10%.
What is West Pharmaceutical Services Inc's Net Income forecast?
Projected CAGR
8%
For the last 8 years the compound annual growth rate for West Pharmaceutical Services Inc's net income is 26%. The projected CAGR for the next 3 years is 8%.